Pfizer Inc. has filed its annual report on Form 11-K with the SEC for the fiscal year ended December 31, 2023. The report includes audited financial statements of the Pfizer Savings Plan, which is available to employees for stock purchase, savings, and similar plans. The independent audit, conducted by KPMG LLP, concluded that the financial statements present fairly the net assets available for plan benefits as of December 31, 2023, and the changes in net assets for the year in accordance with U.S. GAAP. The report details the Plan's investments, including Pfizer Inc. common stock, mutual funds, and other assets totaling approximately $19.7 billion, an increase from the previous year's $18 billion. The Plan experienced a net investment gain of over $2 billion for...Show More

Pfizer Inc. has filed its annual report on Form 11-K with the SEC for the fiscal year ended December 31, 2023. The report includes audited financial statements of the Pfizer Savings Plan, which is available to employees for stock purchase, savings, and similar plans. The independent audit, conducted by KPMG LLP, concluded that the financial statements present fairly the net assets available for plan benefits as of December 31, 2023, and the changes in net assets for the year in accordance with U.S. GAAP. The report details the Plan's investments, including Pfizer Inc. common stock, mutual funds, and other assets totaling approximately $19.7 billion, an increase from the previous year's $18 billion. The Plan experienced a net investment gain of over $2 billion for the year. The report also outlines the Plan's administrative details, contributions, rollovers, and participant-directed investments. Notably, the Plan underwent several mergers and transfers due to Pfizer's acquisitions, including Trillium Therapeutics, Arena Pharmaceuticals, ReViral Ltd., and Global Blood Therapeutics. The Plan is subject to ERISA and the Internal Revenue Code, with no current audits in progress for tax periods. The report also mentions subsequent events, including the acquisition of Seagen Inc. and the transfer of its 401(k) plan into the Pfizer Savings Plan.